Biocon Plots Biosimilars Listing By 2023

Indian Firm Eyeing $1bn In Sales From Biosimilars In Two Years

 
• By Dean Rudge
IPO
An IPO for Biocon Biologics is planned by 2023 • Source: Shutterstock

More from Strategy

More from Business